Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
Status: SUSPENDED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Enobosarm & Abemaciclib Combo|DRUG: non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
Sponsor: Veru Inc.